Which of the following best describes the primary mechanism by which insulin suppresses glucagon secretion from pancreatic alpha cells?

Explanation

## Mechanism of Insulin-Mediated Glucagon Suppression **Key Point:** Insulin does NOT directly inhibit alpha cells via insulin receptors. Instead, insulin stimulates **somatostatin (SST) secretion from pancreatic delta cells**, and somatostatin acts as a paracrine inhibitor of both glucagon and insulin secretion. ### The Paracrine Loop | Cell Type | Hormone | Target | Effect | |-----------|---------|--------|--------| | Beta cell | Insulin | Delta cell | ↑ SST secretion | | Delta cell | Somatostatin | Alpha cell | ↓ Glucagon secretion | | Delta cell | Somatostatin | Beta cell | ↓ Insulin secretion | **High-Yield:** This is a **paracrine inhibition**, not endocrine. Somatostatin acts locally within the islet and has a very short half-life (~3 minutes). ### Why This Matters Physiologically In the **fed state**: 1. Rising glucose → beta cell depolarization → insulin secretion ↑ 2. Insulin → delta cell stimulation → somatostatin ↑ 3. Somatostatin → alpha cell inhibition → glucagon ↓ This prevents the paradoxical situation of high insulin *and* high glucagon simultaneously. **Clinical Pearl:** Somatostatin analogs (octreotide) suppress both insulin and glucagon, making them useful in acromegaly but problematic in diabetes management. [cite:Guyton & Hall 13e Ch 78]